Swissmedic Updates Position Paper on Decentralised Clinical Trials: Key Changes Explained
On October 31, 2025, Swissmedic and swissethics announced an update to their position paper on decentralised clinical trials (DCTs) for…
europe updates on medical device regulation and quality.
258 articles
On October 31, 2025, Swissmedic and swissethics announced an update to their position paper on decentralised clinical trials (DCTs) for…

Swissmedic has announced an important update regarding the therapeutic scope of Omvoh®. The newly approved indication offers enhanced application potential…

Swissmedic has issued an announcement regarding the immediate recall of batch number 251347651 of NaCl B. Braun infusion solution. This…

Swissmedic, Switzerland’s agency for the authorization and supervision of therapeutic products, has announced an extension of the therapeutic indication for…

Swissmedic, the Swiss agency for therapeutic products, has announced the first regulatory authorization for Ayvakyt®. This marks a significant milestone…

Swissmedic, the Swiss agency responsible for licensing and monitoring therapeutic products, has announced the initial authorization for Wainzua®. This development…

Swissmedic has issued an important notice about the risks of intraoperative floppy iris syndrome (IFIS) among patients undergoing cataract surgery…

The latest vigilance report from Swissmedic highlights significant findings regarding adverse reactions to veterinary medicinal products reported in Switzerland during…

Swissmedic has issued a health professional communication regarding a change in the shelf life of Lecigon, a medication containing carbidopa,…

Healthcare professionals, regulators, and distributors should take note of a critical update related to Relonchem Ltd products. The company has…

An urgent recall has been issued for Ipratropium Bromide 500 microgram/2ml Nebuliser Solution by Accord Healthcare Ltd due to incorrect…

Swissmedic has announced the first authorization for Sogroya®, marking a significant regulatory development. The approval introduces a new option within…